CASI Pharmaceuticals (CASIF) Exchange Rate Effect (2022 - 2025)
CASI Pharmaceuticals (CASIF) reported Exchange Rate Effect of $216000.0 for Q4 2025, up 126.97% on a YoY basis from $95168.3 in Q4 2024, and up 796.77% quarter-over-quarter from -$31000.0 in Q3 2025.
CASI Pharmaceuticals (CASIF) Exchange Rate Effect (2022 - 2025) Analysis & Trends
CASI Pharmaceuticals has reported Exchange Rate Effect for 4 years, with the latest figure at $216000.0 in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 126.97% year-over-year to $216000.0; the trailing twelve-month figure through Dec 2025 stood at -$281000.0 (up 73.71% YoY), and the FY2025 full-year result was $713000.0, up 224.22% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $216000.0, up from -$31000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $2.7 million in Q4 2023, with the low at -$3.5 million in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$334062.5 across 4 years, with a median of -$39500.0 in 2024.
- The largest YoY upside for Exchange Rate Effect was 126.97% in 2025 against a maximum downside of 572.92% in 2025.
- CASI Pharmaceuticals' Exchange Rate Effect stood at $1.9 million in 2022, then jumped by 39.91% to $2.7 million in 2023, then tumbled by 130.02% to -$801000.0 in 2024, then surged by 126.97% to $216000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $216000.0 (Q4 2025), -$31000.0 (Q3 2025), and -$12000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 860,679.92 Bn | 860,679.89 Bn | - | - |
| 2 | Belite Bio | 55,284.00 Bn | 55,284.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,206.94 Bn | 16,206.93 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,318.00 Bn | 3,317.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,543.84 Bn | 1,543.84 Bn | - | - |
| 6 | Evaxion A | 1,449.11 Bn | 1,449.09 Bn | - | - |
| 7 | Psyence Biomedical | 216.99 Bn | 216.98 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 115.22 Bn | 107.97 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 90.58 Bn | 90.58 Bn | - | 8.68 Mn |
| 10 | CASI Pharmaceuticals | - | - | 3.69 Mn | 216,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 216,000.00 |
| Dec 31, 2025 | 216,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | -454,000.00 |
| Mar 31, 2025 | -454,000.00 |
| Dec 31, 2024 | -801,000.00 |
| Dec 31, 2024 | -801,000.00 |
| Sep 30, 2024 | -48,000.00 |
| Sep 30, 2024 | -48,000.00 |
| Jun 30, 2024 | -316,000.00 |
| Jun 30, 2024 | -316,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Dec 31, 2023 | 2.67 Mn |
| Dec 31, 2023 | 2.67 Mn |
| Sep 30, 2023 | -171,000.00 |
| Sep 30, 2023 | -171,000.00 |